Libby P.Current concepts of the pathogenesis of the acute coronary syndromes[J].Circulation,2001,104:365-372.
[2]
Lucas AR1,Korol R,Pepine CJ.Inflammation in atherosclerosis:some thoughts about acute coronary syndromes[J].Circulation,2006,113:728-732.
[3]
Panagopoulou V1,Deftereos S,Kossyvakis C,et al.NTproBNP:an important biomarker in cardiac diseases[J].Curr Top Med Chem,2013,13:82-94.
[4]
Bajaj RR1,Goodman SG,Yan RT,et al.Treatment and outcomes of patients with suspected acute coronary syndromes in relation to initial diagnostic impressions(insights from the Canadian Global Registry of Acute Coronary Events [GRACE] and Canadian Registry of Acute Coronary Events [CANRACE])[J].Am J Cardiol,2013,111:202-207.
[5]
Libby P.Mechanisms of acute coronary syndromes and their implications for therapy[J].N Engl J Med,2013,368:2004-2013.
[6]
Yayan J.Emerging families of biomarkers for coronary artery disease:inflammatory mediators[J].Vasc Health Risk Manag,2013,9:4354-4356.
Patel AAI,Budoff MJ.Screening for heart disease:C-reactive protein versus coronary artery calcium[J].Expert Rev Cardiovasc Ther,2010,8(1):125-131.
[11]
Yousuf OI,Mohanty BD,Martin SS,et al.High-sensitivity C-reactive protein and cardiovascular disease:a resolute belief or an elusive link[J].J Am Coll Cardiol,2013,30,62:397-408.
[12]
Dao QKP,Kazanegra R.Utility of B-type natriuretic peptide in the diagnosis of congestive heart failure in an urgent-care setting [J].J Am Coll Cardiol,2001,37:379-385.
[13]
Bassan R,P Maisel A.B-type natriuretic Peptide a novel early blood marker of myocardial infaction in Patients with chest Pain and no ST-segment elevation[J].Eur Heart J,2005,26:234-240.
